PRKN and Parkinson disease: In the present study, the increased level of P-S129 α-SYN in the parkin−/− mice was not associated with increased dopaminergic degeneration, which is intuitively in contradiction with the knowledge that ± 90% of α-SYN within LBs from PD patients is phosphorylated at S129 [34,35].